Citations

Mayo Clinic

Showing 10 of 108551 citations.

Development of Liposomal Formulation for Delivering Anticancer Drug to Breast Cancer Stem-Cell-Like Cells and its Pharmacokinetics in an Animal Model
Ahmad, Ajaz , Mondal, Sujan Kumar , Banerjee‬‬‬‬‬‬‬‬‬, Rintu , Alkharfy, Khalid M. , Mukhopadhyay, Debabrata , Banerjee, Rajkumar

Molecular Pharmaceutics | February 2, 2016 | Volume: 13 | Issue: 3 | Pages: 1081-1088

10.1021/acs.molpharmaceut.5b00900 | PMID 26832839 Get It

A targeted genetic association study of epithelial ovarian cancer susceptibility
Earp, Madalene A. , Winham, Stacey J. , Sicotte, Hugues , Chien, Jeremy , Goodman, Marc T. , Levine, Douglas A. , Monteiro, Álvaro N.A. , Ness, Roberta B., Pearce, Celeste Leigh, Rossing, Mary Anne, Tworoger, Shelley S. , Wentzensen, Nicolas , Bisogna, Maria, Brinton, Louise A. , Brooks‐Wilson, Angela , Carney, Michael E. , Cunningham, Julie M. , Edwards, Robert P., Fogarty, Zachary C. , Iversen, Edwin S., Kraft, Peter , Le, Nhu D. , Lin, Hui‐Yi , Lissowska, Jolanta , Moysich, Kirsten B. , Olson, Sara H. , Pike, Malcolm C. , Rider, David N., Terry, Kathryn L. , Thompson, Pamela J., Vierkant, Robert A. , Vitonis, Allison F., Wu, Anna H. , Phelan, Catherine M., Schildkraut, Joellen M. , Chen, Y. Ann , Sellers, Thomas A. , Goode, Ellen L. , Earp, Madalene, Larson, Nicholas, Larson, Nicholas B. , Permuth, Jennifer B. , Anton‐Culver, Hoda , Bandera, Elisa V. , Berchuck, Andrew , Cook, Linda S. , Cramer, Daniel W. , Doherty, Jennifer A. , Larson, Melissa C. , Modugno, Francesmary , Poole, Elizabeth M. , Berg, David Van Den , Wilkens, Lynne R. , Yang, Hannah , Ziogas, Argyrios , Fridley, Brooke L. , Winham, Stacey J , Tworoger, Shelley S , Vierkant, Robert A , Chien, Jeremey , Monteiro, Alvaro N , Moysich, Kirsten , Lissowska, Jolanta , Brooks-Wilson, Angela R , Lin, Hui-Yi , Fogarty, Zachary C , Kraft, Peter , Goodman, Marc T

Oncotarget | February 2, 2016 | Volume: 7 | Issue: 7 | Pages: 7381-7389

10.18632/oncotarget.7121 | PMID 26848776 Get It

Three-Day-Old Boy With Palmar Pustules
Oza, Vikash S. , Asch, Sarah , Mathes, Erin F.

JAMA Pediatrics | February 2, 2016 | Volume: 170 | Issue: 2 | Pages: 171

10.1001/jamapediatrics.2015.1996 | PMID 26830870 Get It

Diagnosing Testicular Torsion before Urological Consultation and Imaging: Validation of the TWIST Score
Sheth, Kunj , Keays, Mélise , Grimsby, Gwen M. , Granberg, Candace F. , Menon, Vani S. , DaJusta, Daniel , Ostrov, Lauren , Hill, Martinez, Sanchez, Emma, Kuppermann, David , Harrison, Clanton B., Jacobs, Micah A. , Huang, Rong , Burgu, Berk , Hennes, Halim , Schlomer, Bruce J., Baker, Linda A.

Journal of Urology | February 2, 2016 | Volume: 195 | Issue: 6 | Pages: 1870-1876

10.1016/j.juro.2016.01.101 | PMID 26835833 Get It

Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma
Choueiri, Toni K. , Fay, André P. , Velasco, Guillermo de , Tyburczy, Magdalena E. , Hamieh, Lana , Albigès, Laurence , Ho, Thai H. , Song, Jiaxi , Pignon, Jean‐Christophe , Barrios, Pablo M. , Michaelson, M. Dror , Krajewski, Katherine M. , Porta, Camillo , Pal, Sumanta K. , Heng, Daniel Y.C., Gray, Kathryn P. , Kwiatkowski, David J. , Rini, Brian I. , Thorner, Aaron R. , Agarwal, Neeraj , Van Allen, Eliezer M , Bellmunt, Joaquim , McDermott, David F. , Signoretti, Sabina , Ho, Thai , Choueiri, Toni K

Clinical Cancer Research | February 1, 2016 | Volume: 22 | Issue: 10 | Pages: 2445-2452

10.1158/1078-0432.ccr-15-2631 | PMID 26831717 Get It

Abstract Purpose: We examined the hypothesis that mutations in mTOR pathway genes are associated with response to rapalogs in metastatic renal cell carcinoma (mRCC). Experimental Design: We studied a cohort of mRCC patients who were treated with mTOR inhibitors with distinct clinical outcomes. Tumor DNA from 79 subjects was successfully analyzed for mutations using targeted next-generation sequencing of 560 cancer genes. Responders were defined as those with partial response (PR) by RECIST v1.0 or stable disease with any tumor shrinkage for 6 months or longer. Nonresponders were defined as those with disease progression during the first 3 months of therapy. Fisher exact test assessed the association between mutation status in mTOR pathway genes and treatment response. Results: Mutations in MTOR, TSC1, or TSC2 were more common in responders, 12 (28%) of 43, than nonresponders, 4 (11%) of 36 (P = 0.06). Mutations in TSC1 or TSC2 alone were also more common in responders, 9 (21%), than nonresponders, 2(6%), (P = 0.05). Furthermore, 5 (42%) of 12 subjects with PR had mutations in MTOR, TSC1, or TSC2 compared with 4 (11%) of 36 nonresponders (P = 0.03). Eight additional non-mTOR pathway genes were found to be mutated in at least 4 of 79 tumors (5%); none were associated positively with response. Conclusions: In this cohort of mRCC patients, mutations in MTOR, TSC1, or TSC2 were more common in patients who experienced clinical benefit from rapalogs than in those who progressed. However, a substantial fraction of responders (24 of 43, 56%) had no mTOR pathway mutation identified. Clin Cancer Res; 22(10); 2445–52. ©2016 AACR. See related commentary by Voss and Hsieh, p. 2320
Education Considerations: Communication Curricula, Simulated Resuscitation, and Duty Hour Restrictions
DeMartino, Erin S. , Kelm, Diana J. , Srivali, Narat , Ramar, Kannan , Srivali, Narat

American Journal of Respiratory and Critical Care Medicine | February 1, 2016 | Volume: 193 | Issue: 7 | Pages: 801-803

10.1164/rccm.201510-2012rr | PMID 26829354 Get It

Secreted Brain-Derived Neurotrophic Factor and Asthma Severity
Wang, Shengyu , Sathish, Venkatachalem , Freeman, Michelle, Prakash, Y. S. , Thompson, Michael A. , Pabelick, Christina M. , Prakash, Y S , Sathish, Venkatachalem

American Journal of Respiratory Cell and Molecular Biology | February 1, 2016 | Volume: 54 | Issue: 2 | Pages: 297-297

10.1165/rcmb.2015-0265le | PMID 26829500 Get It

Wikis: Using Collaborative Platforms in Graduate Medical Education
Cabrera, Daniel , Cooney, Robert , Cabrera, Daniel

Journal of Graduate Medical Education | February 1, 2016 | Volume: 8 | Issue: 1 | Pages: 99-100

10.4300/jgme-d-15-00567.1 | PMID 26913112 Get It

Specific renal parenchymal‐derived urinary extracellular vesicles identify age‐associated structural changes in living donor kidneys
Turco, Anne E. , Lam, Wing Yan, Đenić, Aleksandar , Miller, Virginia M. , Larson, Joseph J. , Kremers, Walter K. , Jayachandran, Muthuvel , Lam, Wing, Lam, Wing, Rule, Andrew D. , Lieske, John C. , Denic, Aleksandar , Kremers, Walter K

Journal of Extracellular Vesicles | February 1, 2016 | Volume: 5 | Issue: 1 | Pages: No page available

10.3402/jev.v5.29642 | PMID 26837814 Get It

Non‐invasive tests to identify age and early disease‐associated pathology within the kidney are needed. Specific populations of urinary extracellular vesicles (EVs) could potentially be used for such a diagnostic test. Random urine samples were obtained from age‐ and sex‐stratified living kidney donors before kidney donation. A biopsy of the donor kidney was obtained at the time of transplantation to identify nephron hypertrophy (larger glomerular volume, cortex per glomerulus and mean profile tubular area) and nephrosclerosis (% fibrosis, % glomerulosclerosis and arteriosclerosis). Renal parenchymal‐derived EVs in cell‐free urine were quantified by digital flow cytometry. The relationship between these EV populations and structural pathology on the kidney biopsy was assessed. Clinical characteristics of the kidney donors (n=138, age range: 20–70 years, 50% women) were within the normative range. Overall, urine from women contained more EVs than that from men. The number of exosomes, juxtaglomerular cells and podocyte marker–positive EVs decreased (p<0.05) with increasing age. There were fewer total EVs as well as EVs positive for mesangial cell, parietal cell, descending limb of Henle's loop (simple squamous epithelium), collecting tubule‐intercalated cell and monocyte chemoattractant protein‐1 markers (p<0.05) in persons with nephron hypertrophy. The number of EVs positive for intercellular adhesion molecule‐1, juxtaglomerular cell, podocyte, parietal cell, proximal tubular epithelial cell, distal tubular epithelial cell and collecting duct cells were fewer (p<0.05) in persons with nephrosclerosis. EVs carrying markers of cells from the renal pelvis epithelium did not associate with any indices of nephron hypertrophy or nephrosclerosis. Therefore, specific populations of EVs derived from cells of the glomerulus and nephron associate with underlying kidney structural changes. Further validation of these findings in other cohorts is needed to determine their clinical utility.